Optimal Machine Learning Models for Developing Prognostic Predictions in Patients With Advanced Cancer
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Machine learning models, like Kernel Support Vector Machine (KSVM), show high accuracy for predicting 30-day survival in advanced cancer patients. Traditional models offer stability, highlighting the need for data-driven model selection in palliative care.
Area Of Science
- Oncology
- Biostatistics
- Machine Learning
Background
- Accurate prognosis is vital for cancer patient care, especially in palliative settings.
- Machine learning (ML) models are increasingly used, but their comparison with traditional statistical models for cancer prognosis is underexplored.
Purpose Of The Study
- To compare the prognostic accuracy of statistical and ML models for predicting 30-day survival in advanced cancer patients.
- To evaluate model performance using objective clinical data, including blood test results.
Main Methods
- Secondary analysis of the Japan-Prognostic Assessment Tools Validation (J-ProVal) study (2012-2014).
- Included 915 patients from 58 palliative care services in Japan.
- Compared four models: fractional polynomial (FP) regression, Kernel Fisher discriminant analysis (KFDA), Kernel support vector machine (KSVM), and XGBoost, using 17 objective clinical characteristics.
- Primary evaluation metric was the area under the receiver operating characteristic curve (AUC).
Main Results
- Kernel Support Vector Machine (KSVM) achieved the highest predictive accuracy (AUC: 0.834).
- KSVM outperformed fractional polynomial (FP) regression (AUC: 0.799).
- XGBoost showed lower performance, potentially due to dataset size limitations.
Conclusions
- Machine learning, specifically KSVM, demonstrates high predictive accuracy for palliative care survival when sufficient data is available.
- Traditional statistical models offer benefits in stability and interpretability.
- Model selection should be tailored based on specific data characteristics for optimal prognostic prediction.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...